Green River Biotech Co., Ltd.: 2026 Q1 EPS NT$4.15
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Green River Biotech reported strong Q1 2026 financial results with a basic EPS of NT$4.15, operating revenue of NT$870 million, and after-tax net profit of NT$427 million, highlighting solid growth in the biotechnology and medical industry.